2023 Transparency Act Report

  • Corporate

Share this article:

2023 Transparency act report image

Presentation of the report

This report has been prepared in accordance with the Norwegian Transparency Act (the “Transparency Act”) section 5 and summarizes the policies and procedures in Nattopharma AS (“Nattopharma”) with respect to safeguarding of human rights and decent working conditions and provides information on the imolementation and results of NattoPharma’s due diligence.

View the 2023 Transparency Act Report

Download report

Latest news & videos

More news
More news about Wellness & Immune Health

Add Your Heading Text Here

High standard of Quality Since 1882

High standard of Quality Since 1882 

Scientific Expertise

Scientific Expertise 

Fermentation Processes

Fermentation Processes

Customer support & Partnerships

Customer support & Partnerships

Lesaffre Logo

Part of Lesaffre

Gnosis by Lesaffre logo
Facebook Twitter Youtube Linkedin

CORPORATE HEADQUARTER
101 rue de Menin
59700 Marcq-en-Baroeul
France

Careers

Lesaffre Activities

Legal Notices

Cookie Policy

Contact Form Policy

Privacy Policy

Quatrefolic®

MenaQ7®

Red Star® Nutritional Yeast

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month. 

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs. 

 

© Gnosis by Lesaffre • We are a proud business unit of Lesaffre.